MacroGenics to Participate in Upcoming Investor Conferences
November 02, 2023 16:30 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Nov. 02, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based...
PaxMedica Engages Bourne Partners to Explore Future Monetization of Potential Priority Review Voucher (PRV)
November 02, 2023 08:30 ET
|
PaxMedica, Inc.
TARRYTOWN, N.Y., Nov. 02, 2023 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (Nasdaq: PXMD), a pioneering biopharmaceutical company focused on advancing treatments for neurologic disorders, has...
MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference Call
October 31, 2023 16:30 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Oct. 31, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based...
Master the Art of Emotional Intelligence in Pharmaceuticals - A One-Day Training Course (February 12, 2024)
October 31, 2023 09:58 ET
|
Research and Markets
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Working with Emotional Intelligence in the Pharmaceutical and Biopharma Industry Training Course" conference has been added to ...
Elevate Your Leadership Skills in Pharma: Agile Leadership Training for Professionals (March 7-8, 2024)
October 31, 2023 09:53 ET
|
Research and Markets
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Agile Leadership for Pharma and Biopharma Professionals in a hybrid world Training Course" conference has been added to ResearchAndMarkets.com's...
PaxMedica Acquires Suramin Research Assets from Rediscovery Life Sciences to Accelerate NDA Submission for PAX-101
October 31, 2023 08:00 ET
|
PaxMedica, Inc.
TARRYTOWN, New York, Oct. 31, 2023 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (Nasdaq: PXMD), a pioneering biopharmaceutical company specializing in cutting-edge treatments for neurological...
Four Day Stability Testing of Pharmaceuticals and Biopharmaceuticals Virtual Training Course
October 27, 2023 05:38 ET
|
Research and Markets
Dublin, Oct. 27, 2023 (GLOBE NEWSWIRE) -- The "Stability Testing of Pharmaceuticals and Biopharmaceuticals Training Course" conference has been added to ResearchAndMarkets.com's offering.This...
Unlock the Power of Stability Studies: Two-Day Seminar Offers In-Depth Training and Certification (November 13-14, 2023)
October 20, 2023 08:48 ET
|
Research and Markets
Dublin, Oct. 20, 2023 (GLOBE NEWSWIRE) -- The "Stability Testing of Pharmaceuticals and Biopharmaceuticals Training Course" conference has been added to ResearchAndMarkets.com's offering. Prepare...
China's Position in the Global Biopharmaceutical Manufacturing Industry: 2023 Insights - Navigating the Evolving Landscape
October 13, 2023 04:03 ET
|
Research and Markets
Dublin, Oct. 13, 2023 (GLOBE NEWSWIRE) -- The "China's Position in Global Manufacturing: A Comparison of China's Emerging Position vs Established Regions' Manufacturing Capacity and Production"...
Growing Prevalence of Mental Health Disorders and Advancements in Medical Technology Drive the Global Psychobiotics Market to 2033
October 11, 2023 04:28 ET
|
Research and Markets
Dublin, Oct. 11, 2023 (GLOBE NEWSWIRE) -- The "Psychobiotics Market By Psychotropic Agent, By Form, By Application, and by Region - Global Forecast to 2023-2033" report has been added to ...